Micheline MacKay has over 22 years of experience in regulatory environments including pharmaceuticals, medical devices, and government regulated industries. She has held leadership positions in different areas, with a strong focus on business improvements and product development from laboratory scale to commercial operations.
Mrs MacKay has been the corporate manager of Creso Pharma’s wholly-owned Canadian subsidiary, Mernova Medicinal Inc, since June 2019 and is responsible for multiple functions including HR, quality assurance, and regulatory affairs. She is also the Health Canada designated Responsible Person in Charge at Mernova. Mrs MacKay was appointed to the board of Creso Pharma as an executive director in January 2022.